Original Research

Reducing the trigger dose of recombinant hCG in high-responder patients attending an assisted reproductive technology program: an observational study

Tiboni GM, Colangelo EC, Ponzano A

Drug Design, Development and Therapy 2016, 10:1691-1694

Published Date: 18 May 2016